Paul L. Berns, President and CEO at Anacor Pharmaceuticals, Inc. (ANAC), sold 37,500 shares at $59.89 ($2.3M) on 2016-03-22, disclosed to the SEC on 2016-03-22.
Open-market sale of $2.3M ANAC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.89 | 9,700 | $581K | 25.7% |
| 2 | $60.46 | 27,800 | $1.7M | 74.3% |
| Total | $60.31 avg | 37,500 | $2.3M | 100% |
| Filing → |
| NMRA | SELL | 2026-02-19 | $34K | — | Filing → |
| NMRA | SELL | 2025-02-20 | $23K | — | Filing → |
| MTSR | BUY | 2025-02-03 | $14.2M | — | Filing → |